Premature brain aging predicts cognitive decline, dementia risk, and mortality across populations, but measuring it accurately has proven challenging. Different brain age models using varied imaging techniques and algorithms often produce conflicting results, leaving researchers uncertain about which approach captures the most meaningful biological signal. This uncertainty has limited clinical applications and hindered our understanding of what drives accelerated brain aging at the molecular level. An international consortium analyzed brain imaging data from 60,735 individuals across 30 research cohorts worldwide, applying advanced genetic modeling to identify common biological pathways underlying brain aging differences. The analysis revealed that despite using different methodologies, six major brain age prediction models converge on a shared genetic architecture explaining 63% of the total genetic variance. Researchers identified 19 genetic variants linked to this common brain aging factor, including four previously unknown associations. The genetic signature showed strong correlations with blood pressure elevation, smoking behavior, longevity genes, autism spectrum traits, and sleep patterns. Remarkably, polygenic risk scores based on this unified genetic model predicted brain age differences even in childhood, with stronger effects emerging in adulthood. When tested against health databases, the combined genetic score captured associations with more disease traits than any individual brain age model alone. This represents a significant methodological advance in neuroscience research. Rather than debating which brain age model performs best, the field can now focus on the shared biological mechanisms these models collectively identify. The genetic architecture points toward vascular health, lifestyle factors, and neurodevelopmental pathways as key drivers of individual differences in brain aging rates. For longevity research, this unified approach offers a more robust tool for identifying individuals at risk for accelerated cognitive decline decades before symptoms appear.